The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
<h4>Objective</h4>Glucocorticoids (GCs) are often used to treat Rheumatoid Arthritis (RA) despite their many side effects and the availability of other effective therapies. Cataract and glaucoma are known side effects of GCs but the risk of them developing in the setting of GC use for RA...
Saved in:
Main Authors: | Rachel J Black, Catherine L Hill, Susan Lester, William G Dixon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0166468 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Clinical Role of Glucocorticoids in the Management of Rheumatoid Arthritis
by: Al-Mossawi, Hussein, et al.
Published: (2012) -
Trends in the idea of the safety of glucocorticoids in rheumatoid arthritis
by: Yu V Murav'ev, et al.
Published: (2011-04-01) -
Revisiting the question of the safety of glucocorticoids use of in the treatment of rheumatoid arthritis
by: E. A. Aronova, et al.
Published: (2023-07-01) -
EULAR recommendation for the management of rheumatoid arthritis (2013): glucocorticoid use
by: N.V. Chichasova
Published: (2014-05-01) -
NEW GUIDELINES FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE PLACE OF GLUCOCORTICOIDS
by: E. L. Nasonov
Published: (2015-09-01)